Roger Alvarez

Dr. Roger Alvarez

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Western Journal of Nursing Research
Verified
Journal Article
Closed access
PDF file
RARoger Alvarez
Roger Alvarez
EVElias Vasquez
Elias Vasquez
CMCarla C. Mayorga
Carla C. Mayorga
DFDaniel J. Feaster
Daniel J. Feaster
VMVictoria B. Mitrani
Victoria B. Mitrani
Recruitment is one of the most significant challenges in conducting research with ethnic minority populations. Establishing relationships with organizations that serve ethnic minority communities can facilitate recruitment. To create a successful recruitment process, a strategic plan of action is necessary prior to implementing community outreach efforts. For this study population of women who were HIV+ and recovering from substance abuse disorder, the authors found that establishing trust with community organizations that serve these women allows for a productive referral relationship. Although the majority of women in this study are African American, the authors were particularly challenged in recruiting Hispanic women. This article presents a recruitment process model that has facilitated our recruitment efforts and has helped the authors to organize, document, and evaluate their community out-reach strategies. This model can be adopted and adapted by nurses and other health researchers to enhance engagement of minority populations.

1 August 2020 in Chest
Verified
Journal Article
Closed access
SNSteven D. Nathan
Steven D. Nathan
KFKevin.R. Flaherty
Kevin.R. Flaherty
MGMarilyn.K. Glassberg
Marilyn.K. Glassberg
GRGanesh Raghu
Ganesh Raghu
JSJeffrey Swigris
Jeffrey Swigris
LLLisa Lancaster
Lisa Lancaster

1 July 2020 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
RARoger Alvarez
Roger Alvarez
LBLorenzo Berra
Lorenzo Berra
MGMark T. Gladwin
Mark T. Gladwin

1 July 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MRMizanur Rahaman
Mizanur Rahaman
FRFabio G. Reinders
Fabio G. Reinders
DKDavid Koes
David Koes
ANAnh T. Nguyen
Anh T. Nguyen
SMStephanie M. Mutchler
Stephanie M. Mutchler
Adam C. StraubAdam C. Straub
Adam C. Straub
NADH cytochrome b5 reductase 3 (CYB5R3) is critical for reductive reactions such as fatty acid elongation, cholesterol biosynthesis, drug metabolism, and methemoglobin reduction. Although the physiological and metabolic importance of CYB5R3 has been established in hepatocytes and erythrocytes, emerging investigations suggest that CYB5R3 is critical for nitric oxide signaling and vascular function. However, advancement toward fully understanding CYB5R3 function has been limited due to a lack of potent small molecule inhibitors. Because of this restriction, we modeled the binding mode of propylthiouracil, a weak inhibitor of CYB5R3 (IC50 = ∼275 μm), and used it as a guide to predict thiouracil-biased inhibitors from the set of commercially available compounds in the ZINC database. Using this approach, we validated two new potent derivatives of propylthiouracil, ZINC05626394 (IC50 = 10.81 μm) and ZINC39395747 (IC50 = 9.14 μm), both of which inhibit CYB5R3 activity in cultured cells. Moreover, we found that ZINC39395747 significantly increased NO bioavailability in renal vascular cells, augmented renal blood flow, and decreased systemic blood pressure in response to vasoconstrictors in spontaneously hypertensive rats. These compounds will serve as a new tool to examine the biological functions of CYB5R3 in physiology and disease and also as a platform for new drug development.

1 December 2017 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
RARoger Alvarez
Roger Alvarez
MMMegan P. Miller
Megan P. Miller
SHScott A. Hahn
Scott A. Hahn
JGJoseph C. Galley
Joseph C. Galley
EBEileen Bauer
Eileen Bauer
Adam C. StraubAdam C. Straub
Adam C. Straub
Pulmonary hypertension is characterized by pulmonary endothelial dysfunction. Previous work showed that systemic artery endothelial cells (ECs) express hemoglobin (Hb) α to control nitric oxide (NO) diffusion, but the role of this system in pulmonary circulation has not been evaluated. We hypothesized that up-regulation of Hb α in pulmonary ECs contributes to NO depletion and pulmonary vascular dysfunction in pulmonary hypertension. Primary distal pulmonary arterial vascular smooth muscle cells, lung tissue sections from unused donor (control) and idiopathic pulmonary artery (PA) hypertension lungs, and rat and mouse models of SU5416/hypoxia-induced pulmonary hypertension (PH) were used. Immunohistochemical, immunocytochemical, and immunoblot analyses and transfection, infection, DNA synthesis, apoptosis, migration, cell count, and protein activity assays were performed in this study. Cocultures of human pulmonary microvascular ECs and distal pulmonary arterial vascular smooth muscle cells, lung tissue from control and pulmonary hypertensive lungs, and a mouse model of chronic hypoxia-induced PH were used. Immunohistochemical, immunoblot analyses, spectrophotometry, and blood vessel myography experiments were performed in this study. We find increased expression of Hb α in pulmonary endothelium from humans and mice with PH compared with controls. In addition, we show up-regulation of Hb α in human pulmonary ECs cocultured with PA smooth muscle cells in hypoxia. We treated pulmonary ECs with a Hb α mimetic peptide that disrupts the association of Hb α with endothelial NO synthase, and found that cells treated with the peptide exhibited increased NO signaling compared with a scrambled peptide. Myography experiments using pulmonary arteries from hypoxic mice show that the Hb α mimetic peptide enhanced vasodilation in response to acetylcholine. Our findings reveal that endothelial Hb α functions as an endogenous scavenger of NO in the pulmonary endothelium. Targeting this pathway may offer a novel therapeutic target to increase endogenous levels of NO in PH.

1 September 2017 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
KAKyan Askari
Kyan Askari
WSWaleed Sneij
Waleed Sneij
SKStefanie Krick
Stefanie Krick
RARoger Alvarez
Roger Alvarez